Is this email not displaying correctly? View it in your browser.
 
Newswise - News for JournalistsNewswise - pix
Newswise Special Wire
Tuesday, September 1, 2020

Public edition | newswise.com

Newswise Cancer Research Wire for

 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.



Cancer Cells Take Over Blood Vessels to Spread

In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

– Johns Hopkins Medicine

Cancer Research, July-2020; U01CA221007; U54CA2101732 ; 3P30CA006973; U01CA217846


Scientists Develop First Drug-Like Compounds to Inhibit Elusive Cancer-Linked Enzymes

Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family for the first time; its malfunction is associated with several types of cancer.

– Michigan Medicine - University of Michigan

Nature Chemical Biology


Meeting the Challenge: COVID-19 and Back to School

As back-to-school is right around the corner, parents may have questions about how COVID-19 impacts children, especially if your child or a loved one in your home is immunosuppressed due to treatment for cancer or other health conditions. An expert f...

Expert Available

– Rutgers Cancer Institute of New Jersey


McMaster researchers find potential to make brain cancers in children respond better to treatment

Research published today has identified a small molecule compound that can activate the Wnt pathway in non-Wnt subtypes of medulloblastoma, making these aggressive forms of cancer more responsive to therapies.The work also found the Wnt pathway, whic...

– McMaster University

Nature Communications

Embargo expired on 28-Aug-2020 at 05:00 ET


Promising research sheds light on treating deadly bone-marrow disorder

Researchers are beginning to understand more about how to treat a rare but deadly type of blood cancer known as Philadelphia chromosome-negative myeloproliferative neoplasms.

– University of Chicago Medical Center

British Journal of Haematology


Systematic Testing of Environmental Surfaces in a Radiation Oncology Clinic Shows no Detectable SARS-CoV2

It has been hypothesized that SARS-CoV2 spread among people via droplets that come from the nose and mouth or through contact with contaminated objects and surfaces. Researchers at Rutgers Cancer Institute found that environmental surface testing at ...

– Rutgers Cancer Institute of New Jersey

JAMA Oncology, AUG-2020

Embargo expired on 27-Aug-2020 at 11:00 ET


Phase 1 human trials suggest UIC-developed breast cancer drug is safe, effective

A new type of breast cancer drug can help halt progression of disease and is not toxic, according to phase 1 clinical trials.

– University of Illinois at Chicago

Breast Cancer Research and Treatment


Genetic discovery delivers new hope for aggressive breast cancers

Groundbreaking cancer research by the University of South Australia has identified an invasive protein molecule that could be responsible for some of the most aggressive breast cancers.

– University of South Australia


Robotic Lung Cancer Surgery Comes to NYU Langone Hospital–Brooklyn

Travis Geraci, MD, a specialist in minimally invasive robotic lung and esophageal cancer surgery, will spearhead an expansion of cardiothoracic surgical services in Brooklyn.

– NYU Langone Hospital - Brooklyn


LLNL scientists pair 3D bioprinting and computer modeling to examine cancer spread in blood vessels

Lawrence Livermore National Laboratory scientists have paired 3D-printed, living human brain vasculature with advanced computational flow simulations to better understand tumor cell attachment to blood vessels, the first step in secondary tumor forma...

– Lawrence Livermore National Laboratory

Science Advances

Embargo expired on 26-Aug-2020 at 14:00 ET


Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in majority of patients with RET gene fusions

For patients with non-small cell lung cancers marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of patients in a Phase I/II trial.

– University of Texas M. D. Anderson Cancer Center

New England Journal of Medicine

Embargo expired on 26-Aug-2020 at 17:00 ET


Internal Differences: A New Method for Seeing Into Cells

Prof. Ido Amit and his team’s INs-seq technology allows them to see inside tens of thousands of individual cells, at once, in unprecedented detail. The group has already used the method to identify a new subset of cancer-supporting immune cells tha...

– Weizmann Institute of Science

Cell, Aug-2020


The Medical Minute: Understanding pulmonary nodules

Most pulmonary nodules prove harmless. But in some cases, they can be a sign of lung cancer. Learn how doctors find, test and – if necessary – remove nodules from the lungs.

– Penn State Health


Roswell Park Study: Delaying Antiviral Treatment May Boost Immunity in Stem Cell Transplant Recipients

Patients who develop cytomegalovirus infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, a team from Roswell P...

– Roswell Park Comprehensive Cancer Center

Biology of Blood and Marrow Transplantation


Low-cost, customizable microscope takes top biomedical engineering prize

The winners of National Institutes of Health’s 9th annual Design by Biomedical Undergraduate Teams (DEBUT) challenge developed simple and low-cost diagnostics and treatments for conditions such as tuberculosis, cervical cancer, birth defects, and o...

– National Institute of Biomedical Imaging and Bioengineering


Announcements


NCCN Oncology Research Program, with Taiho Oncology, to Explore New Research into Oral Medication Targeting Tumor Suppression Genes

The NCCN Oncology Research Program announced plans to develop a program to scientifically evaluate and facilitate clinical trials on the efficacy of decitabine and cedazuridine with research funding provided by Taiho Oncology.

– National Comprehensive Cancer Network® (NCCN®)


Center for Asian Health Equity awarded $4.25 million CDC grant to prevent colorectal cancer in Illinois

The University of Chicago Medicine's Center for Asian Health Equity has received a five-year, $4.25 million federal grant to increase colorectal cancer screenings, particularly among underserved and rural Illinois communities.

– University of Chicago Medical Center

1 NU58DP006764-01-00


MD Anderson welcomes 15 volunteer board members, honors two new Life Members

The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) has named 15 new members and bestowed its highest honor of Life Member on senior members Regina Rogers of Beaumont and Melvyn N. Klein of Corpus Christi.

– University of Texas M. D. Anderson Cancer Center


Patients at Hackensack Meridian Children’s Cancer Institute Graduate in a Virtual Commencement Ceremony Celebrating the Class of 2020

Hackensack Meridian Joseph M. Sanzari Children’s Hospital is pleased to announce that 29 patients who have undergone treatment at Hackensack Meridian Health Children’s Cancer Institute graduated in a virtual commencement ceremony celebrating the ...

– Hackensack Meridian Health


NCCN Meeting on Blood Cancers Will Be Virtual for the First Time

The NCCN Virtual Nursing Forum and Annual Congress: Hematologic Malignancies (#NCCNhem20) will provide the latest evidence and expert consensus on emerging practices and debates in blood cancer treatment, online October 8-10.

– National Comprehensive Cancer Network® (NCCN®)


Henry A. Pitt, MD, Appointed as Chief of Oncologic Quality at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital

Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, welcomes a new leader to its team of internationally recognized physicians, researchers and administrators.

– Rutgers Cancer Institute of New Jersey


Herbert Irving Comprehensive Cancer Center Earns National Cancer Institute Renewal

The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care and training.

– Columbia University Irving Medical Center


MITRE and Mayo Clinic Announce Strategic Relationship for Research and Development of Platforms with Intelligent Automation

MITRE and Mayo Clinic today announced a strategic relationship to improve public health outcomes. The organizations will work together to conduct research and development on common data elements for oncology, cardiology, and COVID-19.

– MITRE


Expert Pitch


Is 43 Too Young for Colon Cancer? UC San Diego Health Experts Available to Talk About Colorectal Cancer

– University of California San Diego Health


UCLA oncologist available to comment on changing landscape of colon cancer and the death of Chadwick Boseman

– University of California, Los Angeles (UCLA), Health Sciences

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 Lawrence Livermore National Laboratory

 University of Texas M. D. Anderson Cancer Center

 Penn State Health

 Michigan Medicine - University of Michigan

 University of California San Diego Health

 Columbia University Irving Medical Center

 University of California, Los Angeles (UCLA), Health Sciences


Subscribe / Unsubscribe
Edit my preferences

© 2020 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us